Soergel David has filed 4 insider transactions across 1 company since May 2025.
Most recent transaction: a grant/award of 4374 shares of MADRIGAL PHARMACEUTICALS, INC. ($MDGL) on March 04, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Soergel David | Chief Medical Officer | A | Common Stock | 4374 | $0.00 | 11,919.0000 | 22,939,969 | 57.97% | 0.02% |
| March 4, 2026 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Soergel David | Chief Medical Officer | A | Stock Option (Right to Buy) | 5467 | $0.00 | 5,467.0000 | 22,939,969 | 9999.99% | 0.02% |
| May 15, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Soergel David | Chief Medical Officer | A | Common Stock | 7545 | $0.00 | 7,545.0000 | 22,080,246 | 9999.99% | 0.03% |
| May 15, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Soergel David | Chief Medical Officer | A | Stock Option (Right to Buy) | 12839 | $0.00 | 12,839.0000 | 22,080,246 | 9999.99% | 0.06% |